Marshall Wace’s P3 Health Partners PIII Stock Holding History

Marshall Wace’s Portfolio PIII Stock Details PIII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-240	Closed	-$119K	–	4194
2021 Q3	$119K	Buy	+240	New	+$118K	﹤0.01%	2869

Other funds holding PIII

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NIP

Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

RCG

Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

Marshall Wace's PIII Position: Q4 2021 in Review

Marshall Wace sold out of P3 Health Partners (PIII) in Q4 2021, closing a stake of 240 shares — an estimated $119K sold.

Marshall Wace first reported a position in PIII in Q3 2021 and held it in 1 quarter. The position peaked at $119K in Q3 2021. 24 funds tracked by Wall St. Rank hold PIII as of Q4 2021.

Marshall Wace reported no remaining P3 Health Partners position as of Q4 2021 after selling out during the quarter.
Marshall Wace sold 240 P3 Health Partners shares in Q4 2021, an estimated $119K.
Marshall Wace first reported a position in P3 Health Partners in Q3 2021 and held it in 1 quarter.
Marshall Wace's P3 Health Partners position peaked at $119K in Q3 2021.
24 funds tracked by Wall St. Rank held P3 Health Partners as of Q4 2021.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.